Kieran is a Senior Business Manager in the team that provides technology transfer services to the Medical Research Council (MRC, part of UKRI). He also manages philanthropic funding as part of LifeArc’s Rare Disease Translational Challenge.
For the MRC, Kieran supports researchers of the Cell Biology and Neurobiology divisions at the MRC Laboratory of Molecular Biology (LMB) in Cambridge and leads IP management for the Nucleic Acid Therapeutics Accelerator (NATA) based at MRC Harwell. He also oversees licensing of MRC’s portfolio of research tools and reagents that are made available to the wider scientific community.
As part of the Rare Disease Translational Challenge, Kieran is LifeArc’s lead for the network of Innovation Hubs for Gene Therapies. He co-manages the Gene Therapy Innovation Fund and is responsible for several projects funded by LifeArc’s Philanthropic Fund.
Kieran has a master’s degree in chemistry from the University of Oxford and a PhD in chemical biology from the University in Bristol. He then completed a postdoctoral fellowship at the University of British Columbia in Vancouver before joining adMare BioInnovations, a Canadian leader in the translation and commercialisation of life science research. Prior to joining LifeArc, Kieran supported industry partnerships for Queen Mary University of London’s Faculty of Medicine and Dentistry.
